In contrast, TT causes S985 phosphorylation and degradation of p-Y1003 MET, loss of full-length p-Y1234/5 MET, as well as MET-ECD release and this may explain in part why TT caused cancer regression in certain in vivo tumour models [1,2,4,8]. The gene discussed is MET; the disease is cancer.